BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Australian Diabetes Society - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Australian Diabetes Society
X-ORIGINAL-URL:https://staging.diabetessociety.com.au
X-WR-CALDESC:Events for Australian Diabetes Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Melbourne
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20230401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20230930T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20240621T000000
DTEND;TZID=Australia/Melbourne:20240624T235959
DTSTAMP:20240618T033158Z
CREATED:20240618T033033Z
LAST-MODIFIED:20240618T033158Z
UID:10000066-1718928000-1719273599@staging.diabetessociety.com.au
SUMMARY:Highlights from American Diabetes Association (ADA) 84th Scientific Sessions
DESCRIPTION:21-24 June 2024\nJoin us as we bring you the latest highlights from the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando\, FL\, USA\, taking place 21-24 June 2024! \nThe sessions that we will be focusing on: \n\nSURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea\nSELECT Trial—New Looks at Glycemia\, Inflammation\, and Heart Failure\nTHE STEP-HFpEF and STEP-HFpEF-DM Trials—Targeting Obesity to Treat Heart Failure\nThe First Dedicated Kidney Outcome Trial with a GLP-1 Receptor Agonist—Once-Weekly Semaglutide and the FLOW Trial Results\n\nWe will providing a highlight video at the end of each day at the conference. Click here to watch the daily highlight videos as they become available. \nFor any enquiries\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from AstraZeneca\, Lilly and Novo Nordisk.
URL:https://staging.diabetessociety.com.au/event/highlights-from-ada-2024/
CATEGORIES:ADS Educational Events,International Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://staging.diabetessociety.com.au/wp-content/uploads/2024/06/ADS-Event-Highlights_ADA-Jun-2024.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20250625T000000
DTEND;TZID=Australia/Melbourne:20250625T235959
DTSTAMP:20250623T231802Z
CREATED:20250620T050900Z
LAST-MODIFIED:20250623T231802Z
UID:10000089-1750809600-1750895999@staging.diabetessociety.com.au
SUMMARY:Highlights from American Diabetes Association (ADA) 85th Scientific Sessions
DESCRIPTION:Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 85th Scientific Sessions in Chicago\, IL\, USA\, taking place 20-23 June 2025! \nThe sessions that we will be focusing on: \n\nDiabetes and Peripheral Artery Disease—Evolving Role of GLP-1 RA and New Insights from the STRIDE Trial\nEmerging Non-Peptide\, Small Molecule GLP-1 Receptor Agonists—Can They Become Players?\nUnanticipated Hot Topics in GLP-1 +/- GIP RA\n\nWe will providing a highlight videos at the end of the conference. Click here to watch the highlight videos as they become available. \nFor any enquiries\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from Lilly and Novo Nordisk.
URL:https://staging.diabetessociety.com.au/event/highlights-from-ada-2025/
CATEGORIES:ADS Educational Events,International Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://staging.diabetessociety.com.au/wp-content/uploads/2025/06/ADS-Event-Highlights_ADA-Jun-2025.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Melbourne:20260609T000000
DTEND;TZID=Australia/Melbourne:20260609T235959
DTSTAMP:20260601T050331Z
CREATED:20260522T064142Z
LAST-MODIFIED:20260601T050331Z
UID:10000099-1780963200-1781049599@staging.diabetessociety.com.au
SUMMARY:Highlights from American Diabetes Association (ADA) 2026 Scientific Sessions
DESCRIPTION:Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 2026 Scientific Sessions in New Orleans\, LA\, USA\, taking place 5-8 June 2026! \nThe sessions that we will be focusing on: \n\nThe Benefits of Glucagon/GLP-1 Receptor Dual Agonism: Insights from the SYNCHRONIZE™ Phase 3 Studies of Survodutide\nUnlocking the Next Frontier in Treatment of Obesity and Type 2 Diabetes with Retatrutide: A Triple Agonist\, Activating the GIP\, GLP-1 and Glucagon Receptors (TRANSCEND-T2D-1 and TRIUMPH-1 Results)\nREIMAGINE 1\, 2\, 3: Leveraging Amylin and GLP-1 for Type 2 Diabetes Care with CagriSema\nA Phase 2b\, Randomized\, Double-Blind\, Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy\, Safety\, and Tolerability of AZD5004 in Adults with Type 2 Diabetes Mellitus\n\nWe will providing a highlight videos at the end of the conference. Click here to watch the highlight videos as they become available. \nFor any enquiries\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\nThe ADS gratefully acknowledges the support from AstraZeneca\, Boehringer Ingelheim\, Lilly and Novo Nordisk.
URL:https://staging.diabetessociety.com.au/event/highlights-from-american-diabetes-association-ada-2026-scientific-sessions/
CATEGORIES:ADS Educational Events,International Meetings,Virtual Event
ATTACH;FMTTYPE=image/png:https://staging.diabetessociety.com.au/wp-content/uploads/2026/05/ADS-Event-Highlights_ADA-Jun-2026.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
END:VCALENDAR